Highlights and Quick Summary
- Debt/Assets for the quarter ending September 30, 2022 was 13.18% (a 5.02% increase compared to previous quarter)
- Year-over-year quarterly Debt/Assets increased by 31.27%
- Annual Debt/Assets for 2021 was 10.04% (a -57.62% decrease from previous year)
- Annual Debt/Assets for 2020 was 23.69% (a 15.56% increase from previous year)
- Annual Debt/Assets for 2019 was 20.5% (a Infinity% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of Beam Therapeutics Inc.
Most recent Debt/Assetsof BEAM including historical data for past 10 years.Interactive Chart of Debt/Assets of Beam Therapeutics Inc.
Beam Therapeutics Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 13.18% | 12.55% | 10.32% | – |
| 2021 | 10.04% | 12.62% | 16.01% | 19.76% | 10.04% |
| 2020 | 23.69% | 12.22% | 12.06% | 11.08% | 23.69% |
| 2019 | 20.01% | 0.0% | 0.0% | 0.0% | 20.5% |
| 2018 | – | – | – | 0.0% | 0.0% |
| 2017 | – | – | – | – | 50.0% |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology